Group 2F: HER2-low Breast Cancer—Metastatic

Thursday, June 9
2:00 pm – 3:30 pm Eastern Time (US/New York)

Mentor: Christine Hodgdon

Christine Hodgdon was a conservation biologist before her metastatic breast cancer (MBC) diagnosis in April 2015. Her advocacy career began when she launched, an educational resource for MBC patients that includes a searchable clinical trial database. She later co-founded GRASP – Guiding Researchers & Advocates to Scientific Partnerships which empowers patients, clinicians, and researchers to exchange ideas and learn from each other.  She spearheads the MBC Alliance-sponsored Breast Cancer Brain Metastasis (BCBM) Initiative: Marina Kaplan Project with the goal to address the unmet research needs of breast cancer patients living with central nervous system (CNS) metastasis and was a founding committee member of, a resource hub for breast cancer patients living with brain metastasis. She also collaborates with leadership at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center to innovate the INSPIRE (Influencing Science through Patient-Informed Research & Education) Advocacy Program. Her advocacy work is inspired and driven by the loss of many friends to MBC.

Twitter: @christeeny513

Scientist: Myrto Moutafi, M.D., Ph.D. (c)

Myrto Moutafi is a postdoctoral associate in the laboratory of Dr. David Rimm in Yale School of Medicine’s Pathology department. Her research in oncology focuses on different companion diagnostic tests and biomarkers in breast, lung, and head and neck cancer tissues. She obtained her medical degree at National and Kapodistrian University of Athens (NKUA) , Greece, in 2015 and her Master of Science in NKUA Pathology Department in 2019 , where she studied the role of histone deacetylase (HDAC) inhibitors in melanoma cancer as part of her final thesis.

Myrto enjoys being actively involved in the Postdoctoral Association and taking part in initiatives that further improve the postdoc experience.

Twitter: @mkmoutafi